medline.ch Respirationstrakt Neoplasie

	TACTICAL1 Trial Protocol: Targeted Abdominal CT in Conjunction with Lung Cancer Screening to Identify Kidney Cancer and Other Abdominal Conditions: A Randomised Controlled Pilot Study. Eur Urol Oncol Rossi SH, Kitt J, Clark M, Bradley R, Byass O, Cotton S, Holmes T, Kyriazis G, MacLennan G, Manning S, Massey K, Modi R, Myatt A, Pawluk J, Rodrigues JCL, Tariq K, Stephens A, Wood T, Usher-Smith JA, Stewart GD. PMID: 42919785 [PubMed - as supplied by publisher]
	The impact of STAS on recurrence-free and overall survival in T1-2N0 adenocarcinomas: a single-center retrospective study. BMC Cancer Dursun , Y, Kahya Y, Kocaman G, Güne, Karasoy D, Enön S, Dizbay Sak S, Kay. PMID: 42919260 [PubMed - indexed for MEDLINE]
	Durvalumab completion and re-administration after grade 2 radiation pneumonitis following concurrent chemoradiotherapy for unresectable stage III NSCLC: a single-center real-world study. BMC Cancer Aoki S, Ariyasu R, Kamima T, Sato Y, Tokumasu K, Anno W, Ogura Y, Kaneko M, Mun M, Ninomiya H, Nishio M, Yoshioka Y. PMID: 42919171 [PubMed - indexed for MEDLINE]
	PET-Guided Dose Escalation for Stage III Non-Small Cell Lung Cancer: A Randomized Clinical Trial. Int J Radiat Oncol Biol Phys Raman S, Bissonnette JP, Palma DA, Warner A, Wong H, Taremi M, Bezjak A, Faria S, Dagnault A, Plourde ME, Bouchard M, Lok BH, Qu XM, Turgeon GA, Rodrigues GB, Yaremko BP, Yu E, Lavoie C, Ashworth A, Gaede S, Sun A. PMID: 42918583 [PubMed - as supplied by publisher]
	Nivolumab plus relatlimab with platinum-doublet chemotherapy versus nivolumab with platinum-doublet chemotherapy in stage IV or recurrent non-small cell lung cancer: clinical, translational, and patient-reported outcomes results from the phase II RELATIVITY-104 study. Ann Oncol Girard N, Burotto M, Paz-Ares LG, Schenker M, Lingua A, Orlandi F, Naidoo J, Beardsley EK, Velcheti V, Martinengo GL, Felip E, Reck M, Qureshi A, Kasbekar P, Samanta S, Neely J, Garnett-Benson C, McDonald L, Yu JX, Cobo-Dols M. PMID: 42918419 [PubMed - as supplied by publisher]
	Salivary Glycoprofiling via a Machine Learning-Augmented Lectin Microarray for Noninvasive Risk Stratification of Lung Cancer. J Proteome Res Zhang F, Tang Z, Du H, Ma B, Liu X, Chang Z, Zhao Z, Zhang X, Wang J, Zhang C, Wei B, Shu J, Zhang C, Chen M, Xie H, Li Z. PMID: 42918128 [PubMed - indexed for MEDLINE]
	Transition Metal Doped WTe2 Monolayers for Lung Cancer VOC Detection: Adsorption, Electronic Response, and Sensing Performance. Langmuir Chen Y, Wei X, Zhang J, Zhang Y, Lin X, Wei Z, Jia P. PMID: 42917987 [PubMed - indexed for MEDLINE]
	A Mitochondrial Microenvironment-Responsive Fluorescent Sensor Array for Intelligent Analysis of Lung Cancer Cells and Chemotherapeutic Efficacy. Anal Chem Zhang G, Wu Q, Xu M, Zhu G, Zhu M, Zheng P, Pu M, Wang L, Li J, Wang Z. PMID: 42916395 [PubMed - in process]
	Differential Diagnosis of Lung Cancer Using Artificial Intelligence-Based Extracellular Vesicle Analysis: A Pilot Study. ACS Nano Yoon HB, Choi BH, Kim S, Lee EB, Shin H, Kim HK, Choi Y. PMID: 42916089 [PubMed - indexed for MEDLINE]
	Ultrasensitive Breath Analysis of Lung Cancer Biomarkers Using a Carboxyl-Functionalized Hyper-cross-linked Polymer-Based SPME Coupled with GCâ”€MS. Anal Chem Li H, Wang M, Wang M, Yan H. PMID: 42915282 [PubMed - indexed for MEDLINE]
	DeepSpectrum: A Universal and Accurate Spectral Multimodal Analysis Framework for Lung Cancer Diagnosis. Anal Chem Xu H, Qi Y, Shi Y, Lv R. PMID: 42915230 [PubMed - indexed for MEDLINE]
	Acceptability of a web-based decision aid for early-stage non-small cell lung cancer treatment selection: A prospective pilot study. Respir Investig Kobayashi N, Takeda A, Muraoka S, Kubo S, Ishikawa Y, Mizutani S, Enomoto T, Tsurugai Y, Nakayama K, Yonekura Y, Osaka W, Takahashi Y, Yokosuka T, Sanuki N, Kaneko T. PMID: 42914684 [PubMed - as supplied by publisher]
	Prognostic Value of (68)Ga-NOTA-AE105 uPAR PET/CT in Resected Non-Small Cell Lung Cancer: A Single-Center Prospective Study. J Nucl Med Soldath P, Clausen MM, Loft A, Colville-Ebeling B, Langer SW, Knigge U, Binderup T, Petersen RH, Kjaer A. PMID: 42914185 [PubMed - as supplied by publisher]
	Determinants of lung cancer screening follow-up care in community care settings: A qualitative multi-case study in the ACCELL trial. Chest Palazzo L, Hansell L, Wernli KJ, Brown M, Snidarich M, Louie T, Long S, Walsh C, Coronado GD, DeCell Arnp K, Lodhi S, Leone RJ, Wysham N, Triplette M. PMID: 42913880 [PubMed - as supplied by publisher]
	A Phase 1 Trial Investigating the Addition of Papaverine to Stereotactic Body Radiotherapy (SBRT) for Hypoxic Radiosensitization of Lung Tumors. Int J Radiat Oncol Biol Phys Brownstein J, Williams T, Xu-Welliver M, Sebastian N, Ma SJ, Haglund K, Sim A, Benej M, Papandreou I, Qing K, Wei L, Graves E, Denko N. PMID: 42913863 [PubMed - as supplied by publisher]
	LungCheck: Pilot Testing a Theory-Informed Multicomponent Strategy to Increase Lung Cancer Screening in Primary Care Settings. J Am Coll Radiol Groner LK, Reuter K, Moise N, Thomas C, Wisherop C, Tamimi RM, Phillips E. PMID: 42913766 [PubMed - as supplied by publisher]
	Mapping International Lung Cancer Screening Quality Indicators to the American College of Radiology Lung Cancer Screening Registry: A Crosswalk Analysis. J Am Coll Radiol Stoel G, Kazerooni EA, White CS, Teague SD, Edwards K, Burleson J, Frisby KC, Wulfeck M, Baruah D, Groner LK. PMID: 42913765 [PubMed - as supplied by publisher]
	A Multilevel Intervention to Improve Lung Cancer Screening Among Hispanic Patients: A Pilot Randomized Controlled Trial. J Am Coll Radiol Bharucha M, Gutierrez O, Madan A, Echeverria R, Aguilar-Lopez L, Chen WP, Hoyt MA, Llave K, Lee S, Nguyen T, Ziogas A, Sadigh G. PMID: 42913764 [PubMed - as supplied by publisher]
	Biomarker-guided targeted therapy in lung adenocarcinoma: A concise review of precision oncology advances, resistance mechanisms, and emerging strategies. Pathol Res Pract Mall T, Bachhar V, Joshi V, Lin MC, Wu CH, Hung CH, Tsai CI, Chang-Chien GP, Kogularasu S. PMID: 42913055 [PubMed - as supplied by publisher]
	Erratum: Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study. J Clin Oncol Dix DB, Seibel NL, Chi YY, Khanna G, Gratias E, Anderson JR, Mullen EA, Geller JI, Kalapurakal JA, Paulino AC, Perlman EJ, Ehrlich PF, Malogolowkin M, Gastier-Foster JM, Wagner E, Grundy PE, Fernandez CV, Dome JS. PMID: 42912888 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 163986

Seite 1 von 8200



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung